GLPG-3667

N/A

Report date: 2026/05/04 20:01:27
NME

Base Information

Drug NameGLPG-3667
Drug Alias NameGLPG-3667
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsPlaque psoriasisLupus Erythematosus, SystemicDermatomyositis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[22
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGalapagos Nv
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicDermatomyositis
Inactive IndicationsPlaque psoriasis

Other Information

ATC CodeN/A
Related LinksN/A